|
About Us
Medicure Inc. is a drug discovery, development and marketing Company focused on developing effective therapeutics for unmet needs with a focus on novel therapeutics for unmet cardiovascular and cerebral vascular needs, the largest pharmaceutical sector with annual global sales of over US $70 billion. Medicure became a public company in November 1999 and trades under the symbol MPH on the Toronto Stock Exchange (TSX).
Medicure International Inc., located in Barbados, is a subsidiary of Medicure; owning rights to and managing certain technology assets of the Company.
Management Team
Learn more about our Management Team
Board of Directors
See our Board of Directors
Scientific Advisory Board
Learn more about our Scientific Advisory
Careers
Become a part of the Medicure Team
|
|
